We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Revolution in Rapid Testing: A New Generation of Programmable Lateral Flow Assays

By LabMedica International staff writers
Posted on 25 Oct 2021
Researchers have modified and enhanced the commonly used lateral flow assay method by introducing a technique to control the rate of capillary flow, which enables the test strip to carry out multistep chemical reactions following a programmed sequence.

Lateral flow assays (LFTs) have a wide array of applications and can be used to analyze a variety of samples such as urine, blood, saliva, sweat, serum, and other fluids. More...
They are currently used by clinical laboratories, hospitals, and physicians for quick and accurate tests for specific target molecules and gene expression. Other uses for lateral flow assays are food and environmental safety and veterinary medicine for chemicals, diseases, and toxins. LFTs are also used for disease identification, but the most common LFT is the home pregnancy test.

A weakness of the conventional LFA method is that the physical characteristics of capillary flow prevents them from being able to coordinate complex processes that include the application of multiple reagents in a specific sequence with specific delays in between.

In response to this problem, investigators at the Georgia Institute of Technology (Atlanta, USA) recently described a way to control capillary flow by imprinting roadblocks on the flow path with water-insoluble ink and using the gradual formation of a void between a wetted paper and a sheath polymer tape to create timers. Timers were drawn at strategic nodes to hold the capillary flow for a desired period and thereby enabled multiple liquids to be introduced into multistep chemical reactions following a programmed sequence. By modifying the imprint geometry, the investigators could set the time required for a void to form and effectively created timers that blocked capillary flow for a desired duration.

The investigators employed the new technique to develope (i) an LFA with built-in signal amplification to detect human chorionic gonadotropin with an order of magnitude higher sensitivity than the conventional assay and (ii) a device to extract DNA from bodily fluids without relying on laboratory instruments. The latter device has potential for use as a rapid test for detection of Covid-19 infection.

"These tests have been extremely popular for years, mainly because they are so simple to use. You do not send anything to the lab or clinic because these tests do not require any external equipment to operate. This is an advantage," said senior author Dr. Fatih Sarioglu, assistant professor of electrical and computer engineering at the Georgia Institute of Technology. "But there also is a disadvantage. There are limitations to what they can do. By strategically imprinting these timers, we can program the assays to coordinate different capillary flows. That enables multiple liquids to be introduced, and multistep chemical reactions, with optimal incubation times - so, we can perform complex, automated assays that otherwise would normally have to be performed in laboratories. This takes us beyond the conventional LFA."

"We believe this flow technology research will have widespread impact," said Dr. Sarioglu. "This kind of dipstick test is so commonly used by the public for biomedical testing, and now it can be translated into other applications that we do not traditionally consider to be cut out for these simple tests."

The enhanced LFA technique was described in the October 1, 2021, online edition of the journal Science Advances.

Related Links:
Georgia Institute of Technology


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Varicella Zoster Virus Assay
LIAISON VZV Assay Panel (IgG HT, IgM)
New
PBC Assay
Primary Biliary Cholangitis Assays
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Microbiology

view channel
Image: The U.S. FDA-cleared IntelliSep rapid host response diagnostic represents a breakthrough in sepsis care (Photo courtesy of Cytovale)

Rapid Diagnostic Test Slashes Sepsis Mortality by 39%

Sepsis remains one of the most challenging and fatal conditions in contemporary healthcare, accounting for nearly one-third of all hospital-related deaths in the United States. In emergency departments... Read more

Industry

view channel
Image: The knowledge transfer partnership will further develop technology to rapidly diagnose serious and high-risk infectious diseases (Photo courtesy of Aston University)

Aston University and BG Research Partner to Commercialize Groundbreaking Medical Diagnostic

Technology that can rapidly diagnose high-consequence infectious diseases will take a major step forward towards commercialization, thanks to a new partnership. A Knowledge Transfer Partnership (KTP)... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.